Abstract
Prion diseases, also known as transmissible spongiform encephalopathies (TSEs) are infectious and fatal neurodegenerative diseases. So far, there is no therapy available with clinical efficacy. A detailed survey on the discovery of major classes of small molecule antiprion compounds is documented in this review in the hope that it may shine some light on the future direction of drug discovery against prion and other neurodegenerative diseases.
Keywords: Quinacrine, antiprion, prion protein, drug discovery, indole, prion diseases, pyridine dicarbonitrile, thiazole.
Current Topics in Medicinal Chemistry
Title:Prion Chemical Biology: On the Road to Therapeutics?
Volume: 13 Issue: 19
Author(s): Beining Chen, Mark Thompson, Jennifer Louth and Kai Guo
Affiliation:
Keywords: Quinacrine, antiprion, prion protein, drug discovery, indole, prion diseases, pyridine dicarbonitrile, thiazole.
Abstract: Prion diseases, also known as transmissible spongiform encephalopathies (TSEs) are infectious and fatal neurodegenerative diseases. So far, there is no therapy available with clinical efficacy. A detailed survey on the discovery of major classes of small molecule antiprion compounds is documented in this review in the hope that it may shine some light on the future direction of drug discovery against prion and other neurodegenerative diseases.
Export Options
About this article
Cite this article as:
Chen Beining, Thompson Mark, Louth Jennifer and Guo Kai, Prion Chemical Biology: On the Road to Therapeutics?, Current Topics in Medicinal Chemistry 2013; 13 (19) . https://dx.doi.org/10.2174/15680266113136660172
DOI https://dx.doi.org/10.2174/15680266113136660172 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements